Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | -7.51% | -7.51% | +178.26% |
May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
May. 31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
Financials (USD)
Sales 2024 * | 671K | Sales 2025 * | - | Capitalization | 445M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -81M | EV / Sales 2024 * | 663 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.38
x | P/E ratio 2025 * |
-5.45
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Ocugen, Inc.
1 day | -7.51% | ||
1 week | -7.51% | ||
Current month | -7.51% | ||
1 month | +1.91% | ||
3 months | +58.42% | ||
6 months | +310.78% | ||
Current year | +178.26% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 12-12-31 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 22-03-16 | |
Director/Board Member | 74 | 20-04-04 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.6 | -7.51% | 5,092,995 |
24-06-06 | 1.73 | -4.42% | 3,320,680 |
24-06-05 | 1.81 | +1.12% | 3,106,938 |
24-06-04 | 1.79 | +5.29% | 4,288,201 |
24-06-03 | 1.7 | -1.73% | 3,801,052 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+178.26% | 412M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- OCGN Stock